Under the US Patent Law, an invention is patentable only if it is novel and unknown to any person or organisation in the United States. It should also be useful, non-obvious and statutory. The QR678 is a novel pharmaceutical agent, the first of its kind containing ingredients in a combination that was never used before. It has a wide range of use in various conditions pertaining to alopecia and hair loss. It is also a non-obvious invention as it is not related to any prior existing skills in the same domain. This way, the QR678 effortlessly fulfilled the required criterion to obtain its precious USA patent in the year 2017.
The QR678 therapy arrests hair fall & increases the thickness, number and density of existing hair follicles leading to greater coverage in hair loss. The polypeptides used in the formulation are present in our scalp, making it natural growth factor-based treatment. The polypeptides penetrate deep into the scalp and provide nourishment to the scalp, which results in hair growth.
Unlike other treatments that contain minoxidil & finasteride, QR678 therapy is completely devoid of side effects. QR678 received FDA approval for manufacturing and sale by being the most effective therapy for hair regrowth.
HOW DOES IT WORK?